Cargando…
AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis
BACKGROUND: Contrast-enhancing (CE) lesions are an important finding on brain magnetic resonance imaging (MRI) in patients with multiple sclerosis (MS) but can be missed easily. Automated solutions for reliable CE lesion detection are emerging; however, independent validation of artificial intellige...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350445/ https://www.ncbi.nlm.nih.gov/pubmed/37454342 http://dx.doi.org/10.1186/s13244-023-01460-3 |
_version_ | 1785074136685477888 |
---|---|
author | Schlaeger, Sarah Shit, Suprosanna Eichinger, Paul Hamann, Marco Opfer, Roland Krüger, Julia Dieckmeyer, Michael Schön, Simon Mühlau, Mark Zimmer, Claus Kirschke, Jan S. Wiestler, Benedikt Hedderich, Dennis M. |
author_facet | Schlaeger, Sarah Shit, Suprosanna Eichinger, Paul Hamann, Marco Opfer, Roland Krüger, Julia Dieckmeyer, Michael Schön, Simon Mühlau, Mark Zimmer, Claus Kirschke, Jan S. Wiestler, Benedikt Hedderich, Dennis M. |
author_sort | Schlaeger, Sarah |
collection | PubMed |
description | BACKGROUND: Contrast-enhancing (CE) lesions are an important finding on brain magnetic resonance imaging (MRI) in patients with multiple sclerosis (MS) but can be missed easily. Automated solutions for reliable CE lesion detection are emerging; however, independent validation of artificial intelligence (AI) tools in the clinical routine is still rare. METHODS: A three-dimensional convolutional neural network for CE lesion segmentation was trained externally on 1488 datasets of 934 MS patients from 81 scanners using concatenated information from FLAIR and T1-weighted post-contrast imaging. This externally trained model was tested on an independent dataset comprising 504 T1-weighted post-contrast and FLAIR image datasets of MS patients from clinical routine. Two neuroradiologists (R1, R2) labeled CE lesions for gold standard definition in the clinical test dataset. The algorithmic output was evaluated on both patient- and lesion-level. RESULTS: On a patient-level, recall, specificity, precision, and accuracy of the AI tool to predict patients with CE lesions were 0.75, 0.99, 0.91, and 0.96. The agreement between the AI tool and both readers was within the range of inter-rater agreement (Cohen’s kappa; AI vs. R1: 0.69; AI vs. R2: 0.76; R1 vs. R2: 0.76). On a lesion-level, false negative lesions were predominately found in infratentorial location, significantly smaller, and at lower contrast than true positive lesions (p < 0.05). CONCLUSIONS: AI-based identification of CE lesions on brain MRI is feasible, approaching human reader performance in independent clinical data and might be of help as a second reader in the neuroradiological assessment of active inflammation in MS patients. CRITICAL RELEVANCE STATEMENT: Al-based detection of contrast-enhancing multiple sclerosis lesions approaches human reader performance, but careful visual inspection is still needed, especially for infratentorial, small and low-contrast lesions. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13244-023-01460-3. |
format | Online Article Text |
id | pubmed-10350445 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-103504452023-07-18 AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis Schlaeger, Sarah Shit, Suprosanna Eichinger, Paul Hamann, Marco Opfer, Roland Krüger, Julia Dieckmeyer, Michael Schön, Simon Mühlau, Mark Zimmer, Claus Kirschke, Jan S. Wiestler, Benedikt Hedderich, Dennis M. Insights Imaging Original Article BACKGROUND: Contrast-enhancing (CE) lesions are an important finding on brain magnetic resonance imaging (MRI) in patients with multiple sclerosis (MS) but can be missed easily. Automated solutions for reliable CE lesion detection are emerging; however, independent validation of artificial intelligence (AI) tools in the clinical routine is still rare. METHODS: A three-dimensional convolutional neural network for CE lesion segmentation was trained externally on 1488 datasets of 934 MS patients from 81 scanners using concatenated information from FLAIR and T1-weighted post-contrast imaging. This externally trained model was tested on an independent dataset comprising 504 T1-weighted post-contrast and FLAIR image datasets of MS patients from clinical routine. Two neuroradiologists (R1, R2) labeled CE lesions for gold standard definition in the clinical test dataset. The algorithmic output was evaluated on both patient- and lesion-level. RESULTS: On a patient-level, recall, specificity, precision, and accuracy of the AI tool to predict patients with CE lesions were 0.75, 0.99, 0.91, and 0.96. The agreement between the AI tool and both readers was within the range of inter-rater agreement (Cohen’s kappa; AI vs. R1: 0.69; AI vs. R2: 0.76; R1 vs. R2: 0.76). On a lesion-level, false negative lesions were predominately found in infratentorial location, significantly smaller, and at lower contrast than true positive lesions (p < 0.05). CONCLUSIONS: AI-based identification of CE lesions on brain MRI is feasible, approaching human reader performance in independent clinical data and might be of help as a second reader in the neuroradiological assessment of active inflammation in MS patients. CRITICAL RELEVANCE STATEMENT: Al-based detection of contrast-enhancing multiple sclerosis lesions approaches human reader performance, but careful visual inspection is still needed, especially for infratentorial, small and low-contrast lesions. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13244-023-01460-3. Springer Vienna 2023-07-16 /pmc/articles/PMC10350445/ /pubmed/37454342 http://dx.doi.org/10.1186/s13244-023-01460-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Schlaeger, Sarah Shit, Suprosanna Eichinger, Paul Hamann, Marco Opfer, Roland Krüger, Julia Dieckmeyer, Michael Schön, Simon Mühlau, Mark Zimmer, Claus Kirschke, Jan S. Wiestler, Benedikt Hedderich, Dennis M. AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis |
title | AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis |
title_full | AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis |
title_fullStr | AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis |
title_full_unstemmed | AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis |
title_short | AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis |
title_sort | ai-based detection of contrast-enhancing mri lesions in patients with multiple sclerosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350445/ https://www.ncbi.nlm.nih.gov/pubmed/37454342 http://dx.doi.org/10.1186/s13244-023-01460-3 |
work_keys_str_mv | AT schlaegersarah aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis AT shitsuprosanna aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis AT eichingerpaul aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis AT hamannmarco aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis AT opferroland aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis AT krugerjulia aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis AT dieckmeyermichael aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis AT schonsimon aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis AT muhlaumark aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis AT zimmerclaus aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis AT kirschkejans aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis AT wiestlerbenedikt aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis AT hedderichdennism aibaseddetectionofcontrastenhancingmrilesionsinpatientswithmultiplesclerosis |